Ekso Bionics Holdings, Inc.
EKSO
$12.40
$0.403.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -38.31% | 2.37% | -58.44% | -10.14% | 5.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -38.31% | 2.37% | -58.44% | -10.14% | 5.01% |
| Cost of Revenue | -38.17% | -12.60% | -46.48% | -13.07% | -4.12% |
| Gross Profit | -38.43% | 15.39% | -68.94% | -7.43% | 14.56% |
| SG&A Expenses | 15.19% | -16.46% | 2.23% | 0.17% | -7.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.75% | -16.83% | -17.20% | -5.38% | -11.76% |
| Operating Income | -68.57% | 46.87% | -70.24% | -0.12% | 35.34% |
| Income Before Tax | -36.95% | 31.42% | -12.13% | 15.69% | -6.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -36.95% | 31.42% | -12.13% | 15.69% | -6.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.95% | 31.42% | -12.13% | 15.69% | -6.19% |
| EBIT | -68.57% | 46.87% | -70.24% | -0.12% | 35.34% |
| EBITDA | -80.57% | 53.63% | -85.66% | -1.12% | 39.28% |
| EPS Basic | 29.83% | 64.50% | 37.51% | 42.16% | 37.74% |
| Normalized Basic EPS | 41.09% | 64.50% | 37.50% | 43.98% | 37.74% |
| EPS Diluted | 29.83% | 64.50% | 37.51% | 42.16% | 38.80% |
| Normalized Diluted EPS | 41.09% | 64.50% | 37.50% | 43.98% | 37.74% |
| Average Basic Shares Outstanding | 95.17% | 93.21% | 79.42% | 45.78% | 70.56% |
| Average Diluted Shares Outstanding | 95.17% | 93.21% | 79.42% | 45.78% | 70.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |